Trials / Completed
CompletedNCT03117439
Beta-Glucan Driven vs. Empirical Antifungal Therapy in Critically Ill Patients
(1-3)-Beta-D-Glucan Driven vs. Empirical Antifungal Therapy in High Risk Critically Ill Patients A Randomized Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (actual)
- Sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is aimed to compare the duration of standard anti fungal therapy in high risk ICU patients with a strategy driven by BetaDGlucan test result
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | duration of antifungal therapy | Patients in the study group will stop antifungals in presence of a negative result of Beta Glucan Test |
Timeline
- Start date
- 2016-07-01
- Primary completion
- 2018-06-01
- Completion
- 2018-08-01
- First posted
- 2017-04-18
- Last updated
- 2018-08-31
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT03117439. Inclusion in this directory is not an endorsement.